Lactated Ringer's + Dextrose for Induction of Labour
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which IV fluid better initiates labor in pregnant women: a mix of 5% dextrose with Lactated Ringer's or just Lactated Ringer's. The researchers aim to assess whether the combination shortens labor and affects the baby's blood sugar levels. Participants will be randomly divided into two groups, each receiving one of the fluids. The trial seeks first-time mothers with a single baby in a head-down position who are at full term and have not started labor naturally. As a Phase 4 trial, this study involves an FDA-approved treatment and seeks to understand its benefits for more patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for these treatments?
Research has shown that both Lactated Ringer's solution and a mix of 5% dextrose with Lactated Ringer's are generally safe during labor. These fluids are commonly used to maintain hydration and blood pressure. Studies have found that the combination of 5% dextrose and Lactated Ringer's can shorten labor without increasing the likelihood of a C-section, with most patients tolerating it well and no significant rise in side effects. Lactated Ringer's alone is also widely used and considered safe, potentially reducing the need for interventions like oxytocin, a hormone used to induce labor. Both treatments are common in hospitals, and any side effects are usually mild, such as minor swelling at the IV site or slight changes in blood sugar levels, which are rare and generally not serious.12345
Why are researchers enthusiastic about this study treatment?
Researchers are excited about using Lactated Ringer's with 5% dextrose for inducing labor because this combination could provide enhanced energy support to the mother during labor. Unlike traditional options, such as oxytocin that primarily stimulate contractions, the dextrose component in this treatment acts as a quick energy source, potentially improving the mother's endurance and overall labor experience. Additionally, this approach might offer a more balanced fluid management during labor, as Lactated Ringer's helps maintain proper electrolyte levels. These features make this treatment a promising alternative to standard labor induction methods.
What evidence suggests that this trial's treatments could be effective for inducing labor?
Research has shown that adding a small amount of sugar (5% dextrose) to a common IV fluid called Lactated Ringer's can shorten labor. In this trial, one group will receive these sugar-added fluids during labor, which have been associated with shorter labors on average compared to those who do not receive them. However, these fluids do not reduce the likelihood of needing a cesarean section. Another group will receive Lactated Ringer's alone, which studies have also shown can help shorten labor. The trial aims to determine whether adding sugar to Lactated Ringer's can shorten labor without increasing risks like low blood sugar in newborns.13678
Are You a Good Fit for This Trial?
This trial is for pregnant women undergoing labor induction. Specific eligibility criteria are not provided, but typically participants would be those in good health and without conditions that could complicate labor or affect the study outcomes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 5% dextrose and Lactated Ringers or Lactated Ringers alone during labor
Follow-up
Participants and neonates are monitored for safety and effectiveness after delivery
What Are the Treatments Tested in This Trial?
Interventions
- Lactated Ringer's
- Lactated Ringer's and Dextrose 5%
Find a Clinic Near You
Who Is Running the Clinical Trial?
Eastern Virginia Medical School
Lead Sponsor
University of Modena and Reggio Emilia, Italy
Collaborator